Phillip Covington
Family · Greenville, NCNPI 1720139215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 835 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 57 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 835 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- Amgen$1K
- AbbVie$1K
- GSK$859
- Pfizer$690
- plus $7K from 51 others
What the payments were for
- Food & beverage$14,926100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,926 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $63,064 |
| FarxigaDapagliflozin Propanediol | 43 | $46,676 |
| JanuviaSitagliptin Phosphate | 38 | $42,537 |
| Repatha SureclickEvolocumab | 74 | $42,416 |
| EliquisApixaban | 55 | $41,358 |
| JardianceEmpagliflozin | 27 | $19,267 |
| XareltoRivaroxaban | 26 | $15,460 |
| OxycontinOxycodone Hcl | 12 | $14,972 |
| MounjaroTirzepatide | 11 | $13,024 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 47 | $10,465 |
| TrintellixVortioxetine Hydrobromide | 15 | $9,818 |
| Repatha SyringeEvolocumab | 13 | $9,153 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $8,358 |
| Rosuvastatin Calcium | 521 | $8,335 |
| Praluent PenAlirocumab | 16 | $7,439 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,448 | $63,06461 claims |
| PfizerEliquis, Premarin | $690 | $48,15370 claims |
| AstraZenecaFarxiga | $2,112 | $46,67643 claims |
| MerckJanuvia | $113 | $42,53738 claims |
| Boehringer IngelheimJardiance | $366 | $19,26727 claims |
| Johnson & JohnsonXarelto | $221 | $15,46026 claims |
| Lilly USA, LLCMounjaro | $590 | $13,02411 claims |
| GSKShingrix | $859 | $10,46547 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $164 | $9,81815 claims |
| BayerKerendia | $116 | $7,13111 claims |
| AbbVieSynthroid | $1,140 | $4,93543 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Greenville
- Jacob HinesGreenville$53K
- Melissa OttGreenville$13K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.